tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Dyne Therapeutics trading resumes
PremiumThe FlyDyne Therapeutics trading resumes
20d ago
Dyne Therapeutics trading halted, volatility trading pause
Premium
The Fly
Dyne Therapeutics trading halted, volatility trading pause
20d ago
Dyne Therapeutics price target lowered to $13 from $34 at Oppenheimer
Premium
The Fly
Dyne Therapeutics price target lowered to $13 from $34 at Oppenheimer
20d ago
Dyne Therapeutics price target lowered to $31 from $37 at Raymond James
PremiumThe FlyDyne Therapeutics price target lowered to $31 from $37 at Raymond James
28d ago
Dyne Therapeutics price target lowered to $23 from $25 at RBC Capital
Premium
The Fly
Dyne Therapeutics price target lowered to $23 from $25 at RBC Capital
28d ago
Dyne Therapeutics: Promising Clinical Developments and Strategic Positioning Drive Buy Rating
Premium
Ratings
Dyne Therapeutics: Promising Clinical Developments and Strategic Positioning Drive Buy Rating
28d ago
Dyne Therapeutics price target lowered to $41 from $46 at Evercore ISI
PremiumThe FlyDyne Therapeutics price target lowered to $41 from $46 at Evercore ISI
2M ago
Dyne Therapeutics’ DYNE-251 Study Update: A Potential Game-Changer for Duchenne Muscular Dystrophy
Premium
Company Announcements
Dyne Therapeutics’ DYNE-251 Study Update: A Potential Game-Changer for Duchenne Muscular Dystrophy
2M ago
Dyne Therapeutics Announces $200M Public Offering
Premium
Company Announcements
Dyne Therapeutics Announces $200M Public Offering
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100